Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 1, 2009, Pages 235-241

  Gonzalez Jr , Jose M ^a   Hu, Yujie ^a   Gabelt, B'Ann T ^a   Kaufman, Paul L ^a   Peters, Donna M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FIBRONECTIN; HEPARIN II; INTEGRIN; SYNTENIN; UNCLASSIFIED DRUG; HEPARIN; OLIGOPEPTIDE; PEPTIDE FRAGMENT; SYNDECAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR FLOW; ARTICLE; CELL DISRUPTION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVE SITE; FEMALE; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE MICROSCOPY; INCUBATION TIME; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PERFUSION; PHASE CONTRAST MICROSCOPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RHESUS MONKEY; TRABECULAR MESHWORK; ANIMAL; AQUEOUS HUMOR; BINDING SITE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; FLUORESCENCE MICROSCOPY; HUMAN; MACACA; METABOLISM; ORGAN CULTURE TECHNIQUE; SECRETION;

ACTINS; ANIMALS; AQUEOUS HUMOR; BINDING SITES; CATALYTIC DOMAIN; CELLS, CULTURED; FIBRONECTINS; HEPARIN; HUMANS; INTEGRINS; MACACA FASCICULARIS; MACACA MULATTA; MICROSCOPY, FLUORESCENCE; OLIGOPEPTIDES; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; SYNDECANS; TRABECULAR MESHWORK;

EID: 58249092158     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2143     Document Type: Article

References (43)

1. Townsend DJ, Brubaker RF. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest Ophthalmol Vis Sci. 1980;19:256-266.
2. Toris CB, Yablonski ME, Wang Y-L, Camras CB. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999;127: 407-412.
3. Tian BH, Geiger B, Epstein DL, Kaufman PL. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41:619-623.
4. Mettu PS, Deng P-F, Misra UK, Gawdi G, Epstein DL, Rao PV. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 2004;45:2263-2271.
5. Santas AJ, Bahler C, Peterson JA, et al. Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci. 2003;44:4796-4804.
6. Gonzalez JM Jr, Faralli JA, Peters JM, Newman JR, Peters DM. Effect of heparin II domain of fibronectin on actin cytoskeleton and adherens junctions in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:2924-2931.
7. Barry ST, Flinn HM, Humphries MJ, Critchley DR, Ridley AJ. Requirement for Rho in integrin signalling. Cell Adhes Commun. 1997;4:387-398.
8. Saoncella S, Echtermeyer F, Denhez F, et al. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci U S A. 1999;96:2805-2810.
9. Mould A, Humphries MJ. Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J. 1991;10:4089-4095.
10. Sharma A, Askari J, Humphries MJ, Jones E, Stuart D. Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J. 1999;18:1468-1479.
11. Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 2001;61:8586-8594.
12. Woods A, McCarthy J, Furcht L, Couchman J. A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell. 1993;4:605-613.
13. Filla MS, Liu X, Nguyen TD, et al. In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin. Invest Ophthalmol Vis Sci. 2002;43:151-161.
14. Bultmann H, Santas AJ, Peters DMP. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J Biol Chem. 1998;273:2601-2609.
15. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucineaspartic acid-valine. J Biol Chem. 1991;266:15075-15079.
16. Mould AP, Komoriya A, Yamada KM, Humphries MJ. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J Biol Chem. 1991;266: 3579-3585.
17. Peterson TE, Skorstengaard K, Vibe-Pedersen K. Primary structure of fibronectin. In: Mosher DF, ed. Fibronectin. San Diego, CA: Academic Press; 1989;1-23.
18. Peterson JA, Sheibani N, David G, Garcia-Pardo A, Peters DM. Heparin II domain of fibronectin uses alpha 4 beta 1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J Biol Chem. 2005;280:6915-6922.
19. Hu Y, Gabelt BAT, Kaufman PL. Monkey organ-cultured anterior segments: technique and response to H-7. Exp Eye Res. 2006;82: 1100-1108.
20. Barany EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
21. Wayner EA, Kovach NL. Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J Cell Biol. 1992;116:489-497.
22. Yokosaki Y, Matsuura N, Higashiyama S, et al. Identification of the ligand binding site for the integrin alpha 9 beta 1 in the third fibronectin type III repeat of tenascin-C. J Biol Chem. 1998;273: 11423-11428.
23. Woods A, Longley RL, Tumova S, Couchman JR. Syndecan-4 binding to the high affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch Biochem Biophys. 2000;374:66-72.
24. Tumova S, Woods A, Couchman JR. Heparan sulfate chains from glypican and syndecans bind the hep II domain of fibronectin similarly despite minor structural differences. J Biol Chem. 2000; 275:9410-9417.
25. Mahalingam Y, Gallagher JT, Couchman JR. Cellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties. J Biol Chem. 2007; 282:3221-3230.
26. Zhou L, Maruyama I, Li Y, Cheng EL, Yue BYJT. Expression of integrin receptors in the human trabecular meshwork. Curr Eye Res. 1999;19:395-402.
27. Filla MS, David G, Weinreb RN, Kaufman PL, Peters DM. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp Eye Res. 2004;79:61-74.
28. Moyano JV, Maqueda A, Casanova B, Garcia-Pardo A. alpha 4 beta 1 Integrin/ligand interaction inhibits alpha 5 beta 1-induced stress fibers and focal adhesions via down-regulation of RhoA and induces melanoma cell migration. Mol Biol Cell. 2003;14:3699-3715.
29. Rao PV, Deng P-F, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037.
30. Rao PV, Deng PF, Maddala RL, Epstein DL, Li C-Y, Shimokawa H. Expression of dominant negative Rho-binding domain of Rhokinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis. 2005;11:288-297.
31. Rao PV, Deng P, Sasaki Y, Epstein DL. Regulation of myosin light chain phosphorylation in the trabecular meshwork: Role in aqueous humour outflow facility. Exp Eye Res. 2005;80:197-206.
32. Liu X, Hu Y, Filla MS, et al. The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis. 2005;11:1112-1121.
33. Vittitow JL, Garg R, Rowlette LLS, Epstein DL, O'Brien ET, Borras T. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis. 2002;8:32- 44.
34. Holzmann B, Weissman I. Integrin molecules involved in lymphocyte homing to Peyer's patches. Immunol Rev. 1989;108:45-61.
35. Strauch U, Lifka A, Gosslar U, Kilshaw P, Clements J, Holzmann B. Distinct binding specificities of integrins alpha 4 beta 7 (LPAM-1), alpha 4 beta 1 (VLA-4), and alpha IEL beta 7. Int Immunol. 1994;6:263-275.
36. Walsh G, Symon F, Lazarovils A, Wardlaw A. Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology. 1996;89:112-119.
37. Graham KL, Fleming FE, Halasz P, et al. Rotaviruses interact with alpha 4 beta 7 and alpha 4 beta 1 integrins by binding the same integrin domains as natural ligands. J Gen Virol. 2005;86:3397-3408.
38. Humphries JD, Humphries MJ. CD14 is a ligand for the integrin alpha 4 beta 1. FEBS Lett. 2007;581:757-763.
39. Geiger B, Bershadsky A, Pankov R, Yamada KM. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat Rev Mol Cell Biol. 2001;2:793-805.
40. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res. 2001;89:1104-1110.
41. Chen X, Gumbiner BM. Crosstalk between different adhesion molecules. Curr Opin Cell Biol. 2006;18:572-578.
42. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol. 2002;4:E65-E68.
43. Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86:543-561.